Symbiotec Pharmalab logo

Symbiotec Pharmalab MD and chairman

NSE: SYMBIOTECBSE: 544889Pharmaceuticals & Biotechnology

Symbiotec Pharmalab Limited · Face value ₹2 · Listed Sep 2026 · Issue price ₹988
Last close ₹1,250.20down ₹24.50 (1.92%)BSE ₹1,252.25

Share price at the NSE close on 29 Oct 2026. Previous close ₹1,274.70.

29 Oct: open ₹1,266.10, high ₹1,288.00, low ₹1,236.00

Range of traded prices from listing on 1 Sep 2026 to 29 Oct 2026
₹934.20Low, 1 Sep 2026₹1,309.90High, 16 Oct 2026
Market cap
₹8,033 Cr
P/E
No full year
P/B
No balance sheet
Dividend yield
Nonesince listing in Sep 2026
Volume, NSE
3,68,77644.7% delivered

Symbiotec Pharmalab's chairperson and managing director is Anil Satwani, as filed for the quarter to Sep 2026.

Symbiotec Pharmalab board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • Chairperson and managing directorAnil Satwani
  • Company Secretary and Compliance OfficerSalil Jain

6 directors3 independent1 executive2 non-executive

  • Anil Satwani · Chairperson and managing directorExecutive · joined Sep 2002 · reappointed Jul 2026 · 0 months as independent · 1 listed board · 2 committee seats
  • Rohit MantriNominee, non-executive · joined Dec 2018 · 1 listed board
  • Sunita KishnaniIndependent · joined Nov 2025 · reappointed Dec 2025 · 10 months as independent · 2 listed boards · 2 as independent · 4 committee seats, 1 as chair
  • Pratik PatelIndependent · joined Dec 2025 · reappointed Dec 2025 · 9 months as independent · 2 listed boards · 1 as independent · 4 committee seats, 1 as chair
  • Pramod KasatIndependent · joined Jul 2026 · reappointed Aug 2026 · 2 months as independent · 5 listed boards · 5 as independent · 6 committee seats, 1 as chair
  • Dhananjay MungaleNominee, non-executive · joined Aug 2026 · 3 listed boards · 3 as independent · 2 committee seats, 1 as chair

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

1 director who left
  • Hariharnath Buggana, left 5 Aug 2026: Others

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 21 Sep 20265 of 6 present2 independent · 23 days in between
    • 28 Aug 20266 of 6 present3 independent · no day in between
    • 27 Aug 20265 of 6 present3 independent · 8 days in between
    • 18 Aug 20266 of 6 present3 independent · 11 days in between
    2 earlier meetings
    • 6 Aug 20265 of 5 present3 independent · 36 days in between
    • 30 Jun 20265 of 5 present2 independent
  • Audit Committee

    Chair Sunita Kishnani

    Anil Satwani, Pratik Patel, Pramod Kasat

    • 21 Sep 20263 of 4 present3 independent · 24 days in between
    • 27 Aug 20263 of 4 present3 independent · 8 days in between
    • 18 Aug 20264 of 4 present3 independent · 11 days in between
    • 6 Aug 20263 of 3 present2 independent · 36 days in between
    1 earlier meeting
    • 30 Jun 20263 of 3 present2 independent
  • Nomination and remuneration committee

    Chair Pratik Patel

    Sunita Kishnani, Rohit Mantri

    • 6 Aug 20262 of 2 present2 independent · 36 days in between
    • 30 Jun 20263 of 3 present2 independent
  • Stakeholders Relationship Committee

    Chair Pratik Patel

    Sunita Kishnani, Anil Satwani

    No meeting listed in the filing.

  • Risk Management Committee

    Chair Anil Satwani

    Rohit Mantri, Sunita Kishnani, Raghavender Ramachandran, Salil Jain

    No meeting listed in the filing.

  • Corporate Social Responsibility Committee

    Chair Anil Satwani

    Rohit Mantri, Pratik Patel

    • 30 Jun 20264 of 4 present1 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Jun 2026.

  • S R B C & CO LLPPeer-review certificate valid to Feb 2029

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved
22Sep 26

Open at the quarter's end

0Sep 26
None open at any quarter's end.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
Yes
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.

How money raised was used

The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it.